1. Home
  2. WOR vs ADPT Comparison

WOR vs ADPT Comparison

Compare WOR & ADPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Worthington Enterprises Inc.

WOR

Worthington Enterprises Inc.

HOLD

Current Price

$52.74

Market Cap

2.8B

ML Signal

HOLD

Logo Adaptive Biotechnologies Corporation

ADPT

Adaptive Biotechnologies Corporation

HOLD

Current Price

$18.46

Market Cap

2.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WOR
ADPT
Founded
1955
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Aerospace
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
2.5B
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
WOR
ADPT
Price
$52.74
$18.46
Analyst Decision
Buy
Strong Buy
Analyst Count
3
10
Target Price
$59.67
$16.60
AVG Volume (30 Days)
137.4K
1.9M
Earning Date
12-16-2025
02-05-2026
Dividend Yield
1.43%
N/A
EPS Growth
150.90
N/A
EPS
2.13
N/A
Revenue
$1,253,567,000.00
$252,754,000.00
Revenue This Year
$17.70
$50.86
Revenue Next Year
$5.30
$0.53
P/E Ratio
$24.90
N/A
Revenue Growth
7.43
42.57
52 Week Low
$39.05
$6.26
52 Week High
$70.91
$20.76

Technical Indicators

Market Signals
Indicator
WOR
ADPT
Relative Strength Index (RSI) 47.28 59.49
Support Level $52.28 $16.55
Resistance Level $54.29 $19.16
Average True Range (ATR) 1.27 1.00
MACD 0.13 0.18
Stochastic Oscillator 54.63 82.08

Price Performance

Historical Comparison
WOR
ADPT

About WOR Worthington Enterprises Inc.

Worthington Enterprises Inc is a designer and manufacturer of products and services, including manufactured metal products. The company operates under two reportable operating segments: Consumer Products and Building Products. The consumer Products business has a diverse product offering in the tools, outdoor living and celebrations categories, including propane-filled cylinders for torches, handheld torches, specialized hand tools, drywall tools, accessories and gas grills, and others. And the Building Products business engaged in providing pressurized containment solutions, providing critical components in the residential, non-residential, and repair and remodel end markets through essential categories. The company derives majority of the revenue from Building Products segment.

About ADPT Adaptive Biotechnologies Corporation

Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers, including diffuse large B-cell lymphoma (DLBCL).

Share on Social Networks: